Tatsuya Ito
Head And Neck Surgery
Tokyo, 1600023, Japan
Tokyo, 1600023, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial.
Journal: Current oncology (Toronto, Ont.)
Published: December 17, 2025
Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status.
Journal: Anticancer research
Published: December 16, 2025
Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil Therapy on Synchronous Early-Stage Oropharyngeal/Hypopharyngeal Cancer in Patients With Esophageal Cancer.
Journal: Head & neck
Published: November 04, 2025
History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma.
Journal: Head & neck
Published: October 11, 2025
Salvage surgery following boron neutron capture therapy in a case of recurrent hypopharyngeal cancer after radiotherapy: Surgical and pathological insights.
Journal: Auris, nasus, larynx
Published: October 03, 2025
Hematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Pembrolizumab.
Journal: Asia-Pacific journal of clinical oncology
Published: July 11, 2025
Usefulness of Upfront Neck Dissection Before Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma.
Journal: In vivo (Athens, Greece)
Published: August 19, 2024
Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer.
Journal: Anticancer research
Published: June 14, 2024
Lemierre's Syndrome after Head and Neck Photoimmunotherapy for Local Recurrence of Nasopharyngeal Carcinoma.
Journal: Case reports in oncology
Published: November 14, 2023
Last Updated: 09/26/2026